LB1 Distinguishing favorable from non-favorable prostate cancer with novel prognostic proteomics prostate cancer biopsy test, ProMark™

Autor: Saad, F., Dunyak, J., Shipitsin, M., Choudhury, S., Capela, T., Ernst, C., Hurley, A., Kaprelyants, A., Hussain, S., Chang, H., Nifong, T., Latour, M., Coupal, L., Berman, D., Blume-Jensen, P.
Zdroj: In European Urology Supplements November 2014 13(5):169-169
Databáze: ScienceDirect